Zacks Investment Research
06 Oct 2026, 08:40 UTC · 1h ago
New Strong Sell Stocks for October 6th
Impact · against what's priced in
Earnings estimate revisions create negative pressure for Accendra Health and Cameco, while AB Volvo faces a marginal decline. The shift is most severe for Accendra Health, where a massive revision likely implies a move into annual losses.
- CCJ−0.40
Challenges what's priced in
- The price assumes
The current 30.9% free-cash-flow margin, which the price assumes can at least be maintained.
The 12.2% downward revision in current year earnings estimates challenges the stability of the margins and earnings levels the market currently assumes.
What CCJ's price assumes · Sep 1
